|
Home | Technology News Search Engine:
|
|
|
|
Home: Technology News:
|
|
|
(IT-NEWSWIRE.COM, June 17, 2021 ) According to the new market research report Single use Bioreactors Market is projected to reach USD 3.9 billion by 2025 from USD 1.7 billion in 2020, at a CAGR of 18.0% during the forecast period.
Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=49113750
Increasing adoption of SUBs among small companies and startups, technological advancements in SUBs, reduced automation complexity, ease in the cultivation of marine organisms, reduced energy and water consumption, the growing biologics market and increasing Biopharmaceutical R&D are factors driving the growth of this market.
Based on product, the Single use Bioreactors Market is categorized into single-use bioreactor systems, single-use media bags, single-use filtration assemblies, and other products such as single-use vessels, tubing, connectors, control systems, and probes/sensors, among others. The single-use bioreactor systems segment dominated the market in 2019. SUB systems offer benefits such as lower capital investment, lower operating expenses, and lower environmental footprint, thus driving the growing adoption of these systems in biopharma applications.
The prominent players operating in the Single use Bioreactors Market are Thermo Fisher Scientific (US), Sartorius Stedim Biotech (France), Danaher Corporation (US), and Merck Millipore (Germany).
Opportunity: Emerging markets
The significant growth opportunities offered by emerging countries such as China, India, and Indonesia can be attributed to high growth in their respective pharmaceutical & biopharmaceutical sectors due to the presence of less-stringent regulatory policies as well as low-cost and skilled labor. Owing to cost advantages and skilled labor, these countries are a hub for bioprocess outsourcing. Developing countries are showing faster growth rates in single-use systems. For example, many of the new bioprocessing facilities are expected to be constructed in China to meet both domestic demand and its desire to become an exporter of biopharmaceuticals. China’s biopharma companies also have found CMOs in China to be more open-minded in adopting single-use technology, as compared to domestic biologics developers/manufacturers. In 2018, Wuxi Biologics partnered with ABEC and installed its 4,000-liter Custom Single Run disposable bioreactors for its new commercial manufacturing facility in Wuxi city, China.
Request For Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=49113750
In 2019, North America accounted for the largest share of the single-use bioreactors market, followed by Europe. The large share of the North American regional segment can be attributed to the presence of a well-established biopharmaceutical industry and major players operating in the market.
Contact:
Mr. Aashish Mehra
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA: +1-888-600-6441
sales@marketsandmarkets.com
MarketsandMarkets™
Mr. Aashish Mehra
1-888-600-6441
raviraj.tak@marketsandmarkets.com
Source: EmailWire.Com 
Source: EmailWire.com
|
|
|
|
|
Technology News Headlines
|
|
|
|
|
Technology Business Video Feed
|
|
More Technology Video Feeds
|
|
|
